Welcome to LookChem.com Sign In|Join Free

CAS

  • or

601-53-6

Post Buying Request

601-53-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (5r,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopen

    Cas No: 601-53-6

  • USD $ 100.0-2000.0 / Gram

  • 100 Gram

  • 50 Kilogram/Month

  • SHANGHAI SYSTEAM BIOCHEM CO., LTD
  • Contact Supplier

601-53-6 Usage

Uses

5β-Cholestan-3-one is a metabolite of cholesterol and is used to asses the biosynthesis of cholesterol.

Check Digit Verification of cas no

The CAS Registry Mumber 601-53-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,0 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 601-53:
(5*6)+(4*0)+(3*1)+(2*5)+(1*3)=46
46 % 10 = 6
So 601-53-6 is a valid CAS Registry Number.
InChI:InChI=1/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-20,22-25H,6-17H2,1-5H3/t19-,20-,22+,23-,24+,25+,26+,27-/m1/s1

601-53-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 5β-cholestan-3-one

1.2 Other means of identification

Product number -
Other names 5beta-Cholestan-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:601-53-6 SDS

601-53-6Synthetic route

Conditions
ConditionsYield
With sodium bromate; ruthenium trichloride; tetrabutylammomium bromide In dichloromethane; water at 25℃; for 1.5h;98%
With oxygen; acetaldehyde; ruthenium trichloride; cobalt(II) acetate Ambient temperature; other reagent: peracetic acid, other catalyst: RuCl3*nH2O;98%
With tert.-butylhydroperoxide; pentafluorobenzeneseleninic acid In benzene for 4h; Heating;90%
3,3-ethylenedioxy-5β-cholestane
25328-53-4

3,3-ethylenedioxy-5β-cholestane

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With Montmorillonite K 10; water In acetone for 3h; Heating;97%
1,3-dithiane of cholestanone
39854-45-0

1,3-dithiane of cholestanone

A

1,2-dithiolane
557-22-2

1,2-dithiolane

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With tetrafluoroboric acid; tris(2,2'-bipyridine)iron(III) perchlorate In tetrahydrofuran; water; acetonitrile for 0.0833333h; Ambient temperature;A n/a
B 96%
Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With ammonium formate; palladium on activated charcoal In methanol for 1h; Heating;95%
With sodium dithionite; 2-methyl-5-(prop-1-en-2-yl)cyclohexanone; sodium hydrogencarbonate In 1,4-dioxane at 50℃;89%
With hydrogen; <((t-Bu)2PH)PdP(t-Bu)2>2 saturated with oxygen In tetrahydrofuran under 760 Torr; for 12h; Ambient temperature;86%
3-nitrocholest-2-ene

3-nitrocholest-2-ene

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With water; magnesium; cadmium(II) chloride In tetrahydrofuran for 0.25h; Ambient temperature;95%
5β-cholestan-3-ol
566-84-7

5β-cholestan-3-ol

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With oxone; 2-iodo-3,4,5,6-tetramethylbenzoic acid In nitromethane at 20℃; for 18h;92%
With nitroacetic acid ethyl ester; triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran room temperature for 2 h, refluxed for 2 h;77%
With C55H49N4OP2Ru In toluene under 750.075 Torr; Inert atmosphere; Schlenk technique; Reflux; Green chemistry;76%
With tetrabutylammonium chlorochromate In chloroform for 32h; Heating;75%
With jones reagent In acetone for 0.333333h; Ambient temperature;3.6 mg
epicoprostanol
516-92-7

epicoprostanol

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With osmium(VIII) oxide; acetic acid In diethyl ether for 30h; Ambient temperature;90%
With cyclohexanone; nickel; toluene
N-[(5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-(3E)-ylidene]-N'-phenyl-hydrazine

N-[(5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-(3E)-ylidene]-N'-phenyl-hydrazine

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With BTIB In water; acetonitrile at 0℃; for 0.5h;85%
4β-Phenylsulfonyl-5β-cholestan-3-one
287389-75-7

4β-Phenylsulfonyl-5β-cholestan-3-one

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With methanol; sodium amalgam In tetrahydrofuran Reduction;80%
Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

C

5β-cholestan-3-ol
566-84-7

5β-cholestan-3-ol

Conditions
ConditionsYield
With hydrogen; Cu/Al2O3 In toluene at 60℃; under 760 Torr;A 14%
B 75%
C 5%
3α-Cholestanylnitrit
5493-36-7, 5493-37-8, 55955-17-4

3α-Cholestanylnitrit

A

epicoprostanol
516-92-7

epicoprostanol

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
In solid for 142h; Irradiation;A 8%
B 65%
(3S,5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-3-nitrosooxy-hexadecahydro-cyclopenta[a]phenanthrene

(3S,5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-3-nitrosooxy-hexadecahydro-cyclopenta[a]phenanthrene

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
In solid for 76h; Irradiation;A 5%
B 64%
(5β-cholestan-3α-yl)-methyl ether
29365-27-3

(5β-cholestan-3α-yl)-methyl ether

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With 3,3-dimethyldioxirane In acetone for 18h; Ambient temperature;57%
/PBKTC004-1560/

/PBKTC004-1560/

A

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
IrH5(P-(i-Pr)3)2 In various solvent(s) at 100℃; for 30h;A 55%
B 13%
/PBKTC004-1550/

/PBKTC004-1550/

A

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
IrH5(P-(i-Pr)3)2 In various solvent(s) at 100℃; for 20h;A 52%
B 41%
epicholesterol
474-77-1

epicholesterol

A

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

B

dihydrocholesterone
566-88-1

dihydrocholesterone

C

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
nickel In xylene at 135 - 140℃; for 1h; Heating;A 28%
B 4.5%
C 2.5%
cholesterol
57-88-5

cholesterol

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With nickel at 220℃;
With nickel at 240℃;
epicoprostanol
516-92-7

epicoprostanol

A

coprostanone
601-53-6

coprostanone

B

3.4-seco-5β-cholestanedioic acid-(3.4)
1177-97-5

3.4-seco-5β-cholestanedioic acid-(3.4)

Conditions
ConditionsYield
With chromium(VI) oxide; acetic acid at 60℃;
With chromium(VI) oxide; acetic acid
cholesterol
57-88-5

cholesterol

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With hydrogenchloride; jones reagent; hydrogen 1.) acetone, r.t.; 2.) methanol; Multistep reaction;
Cholest-5-en-3-one
601-54-7

Cholest-5-en-3-one

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With hydrogen; Nic In tetrahydrofuran; ethanol at 25℃; under 760 Torr; for 0.533333h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With hydrogen; palladium In pyridine at 25℃; under 760 Torr; Rate constant; selectivity to 5β compound;
With hydrogen bromide; hydrogen; palladium In tetrahydrofuran at 25℃; under 760 Torr; Rate constant; selectivity to 5β compound;
With hydrogen; Nic In tetrahydrofuran; ethanol at 25℃; under 760 Torr; for 0.6h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
cholesta-4,6-dien-3-one
566-93-8

cholesta-4,6-dien-3-one

A

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

B

dihydrocholesterone
566-88-1

dihydrocholesterone

C

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) In chloroform for 4h; Ambient temperature; Yield given. Yields of byproduct given;
cholesta-1,4-dien-3-one
566-91-6

cholesta-1,4-dien-3-one

A

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

B

dihydrocholesterone
566-88-1

dihydrocholesterone

C

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) In chloroform for 1h; Ambient temperature; Yield given. Yields of byproduct given;
1-[(8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-ylidene]-pyrrolidinium; perchlorate

1-[(8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-ylidene]-pyrrolidinium; perchlorate

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With 1-Benzyl-1,4-dihydronicotinamide; water 1.) acetonitrile, 40 h, reflux 2.) acetonitrile, reflux, 1 h; Multistep reaction. Yields of byproduct given;
Δ4-Cholesten-3-one ethylene dithioacetal
2791-51-7

Δ4-Cholesten-3-one ethylene dithioacetal

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
With dihydrogen peroxide; diborane 1.) THF, 0 deg C, 5 h, 2.) THF, 0 deg C, 5 min; Yield given. Multistep reaction;
With dihydrogen peroxide; diborane In tetrahydrofuran at 0℃; Mechanism; other Δ4-steroids;
Conditions
ConditionsYield
With sodium phosphate buffer; Eubacterium coprostanoligenes ATCC 51222; sodium pyruvate; sodium 2-mercaptoacetate In water at 37℃; for 120h; Product distribution; Mechanism;
diethyl ether
60-29-7

diethyl ether

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

aged platinum

aged platinum

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
Hydrogenation;
diethyl ether
60-29-7

diethyl ether

Cholest-4-en-3-one
601-57-0

Cholest-4-en-3-one

palladium

palladium

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
Hydrogenation;
cholesterol
57-88-5

cholesterol

nickel

nickel

A

dihydrocholesterone
566-88-1

dihydrocholesterone

B

coprostanone
601-53-6

coprostanone

Conditions
ConditionsYield
at 220℃; sowie auf 240grad;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

coprostanone
601-53-6

coprostanone

[(5R,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy]-trimethyl-silane
23400-63-7

[(5R,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy]-trimethyl-silane

Conditions
ConditionsYield
With chiral lithium amide ((R)-5b) In hexane; toluene at -78℃; for 0.333333h;99%
coprostanone
601-53-6

coprostanone

formic acid ethyl ester
109-94-4

formic acid ethyl ester

2-hydroxymethylene-5β-cholestan-3-one
2493-32-5, 17130-63-1, 53585-15-2

2-hydroxymethylene-5β-cholestan-3-one

Conditions
ConditionsYield
With ethanol; sodium In diethyl ether99%
coprostanone
601-53-6

coprostanone

ethylene glycol
107-21-1

ethylene glycol

3,3-ethylenedioxy-5β-cholestane
25328-53-4

3,3-ethylenedioxy-5β-cholestane

Conditions
ConditionsYield
With montmorillonite K-10 In benzene for 2h; Heating;98%
coprostanone
601-53-6

coprostanone

epicoprostanol
516-92-7

epicoprostanol

Conditions
ConditionsYield
With sodium tetrahydroborate In ethanol at 0℃; for 0.0833333h;95%
With lithium aluminium tetrahydride; diethyl ether
Multi-step reaction with 2 steps
1: sodium; ethanol
2: sodium pentylate; amyl alcohol
View Scheme
Multi-step reaction with 2 steps
2: sodium ethylate; ethanol / 180 - 210 °C
View Scheme
coprostanone
601-53-6

coprostanone

4β-chloro-5β-cholestan-3-one
54786-78-6

4β-chloro-5β-cholestan-3-one

Conditions
ConditionsYield
With potassium chlorate; sulfuric acid In 1,4-dioxane at 45℃; for 0.833333h;90.4%
coprostanone
601-53-6

coprostanone

acetic anhydride
108-24-7

acetic anhydride

2-cholestene-3-ol acetate

2-cholestene-3-ol acetate

Conditions
ConditionsYield
With iodine for 0.0833333h; Acetylation; microwave irradiation;90%
coprostanone
601-53-6

coprostanone

4β-bromo-5β-cholestan-3-one
4657-43-6

4β-bromo-5β-cholestan-3-one

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; bromine In water; acetic acid at 20℃; for 16h; Bromination;85%
With hydrogen bromide; bromine; acetic acid
With tetrachloromethane; N-Bromosuccinimide unter starker Belichtung;
methanol
67-56-1

methanol

coprostanone
601-53-6

coprostanone

5β-cholestan-3-one dimethyl acetal
18003-81-1

5β-cholestan-3-one dimethyl acetal

Conditions
ConditionsYield
at 20℃; for 12h; acetalization; UV-irradiation;85%
With toluene-4-sulfonic acid
With hydrogen; Wilkinson's catalyst
bis(methylsulfanyl)trimethylsilylmethane
37891-79-5

bis(methylsulfanyl)trimethylsilylmethane

coprostanone
601-53-6

coprostanone

3-[bis(methylthio)methylene]cholestane
56772-73-7

3-[bis(methylthio)methylene]cholestane

Conditions
ConditionsYield
Stage #1: bis(methylsulfanyl)trimethylsilylmethane With n-butyllithium In tetrahydrofuran; hexane at -78 - 0℃; for 4h;
Stage #2: coprostanone In tetrahydrofuran; hexane at 20℃; for 12h;
85%
coprostanone
601-53-6

coprostanone

ethane-1,2-dithiol
540-63-6

ethane-1,2-dithiol

5β-cholestan-3-one dithiolane
2791-44-8

5β-cholestan-3-one dithiolane

Conditions
ConditionsYield
tin(ll) chloride for 0.0833333h; microwave irradiation;84%
coprostanone
601-53-6

coprostanone

cholesta-1,4-dien-3-one
566-91-6

cholesta-1,4-dien-3-one

Conditions
ConditionsYield
With benzeneseleninic anhydride In chlorobenzene at 132℃; for 3h;83%
Multi-step reaction with 2 steps
1: 114 mg / pyridine hydrobromide perbromide / acetic acid / 0.5 h / 60 °C
2: CaCO3 / N,N-dimethyl-acetamide / 30 h / Heating
View Scheme
coprostanone
601-53-6

coprostanone

2α-Bromcholestan-3-on
881739-66-8

2α-Bromcholestan-3-on

Conditions
ConditionsYield
With hexabromocyclopenta-1,3-diene In acetonitrile for 15h; Heating;77%
Conditions
ConditionsYield
With hydrogen; carbon monoxide In methanol at 30 - 35℃; under 51485.6 - 73550.8 Torr; for 2.5h;75%
With hydrogen bromide; acetic acid; platinum at 60 - 65℃; Hydrogenation.Behandlung des Reaktionsprodukts mit aethanol. Alkalilauge;
With intestine bacteria
Reduktion unter Einwirkung von Darm-Bakterien;
coprostanone
601-53-6

coprostanone

ethane-1,2-dithiol
540-63-6

ethane-1,2-dithiol

5α-cholestan-3-one ethanediyl S,S-acetal
2791-43-7

5α-cholestan-3-one ethanediyl S,S-acetal

Conditions
ConditionsYield
With boron trifluoride diacetate for 0.25h;70%
coprostanone
601-53-6

coprostanone

5β-cholestane-3,4-dione 4-oxime

5β-cholestane-3,4-dione 4-oxime

Conditions
ConditionsYield
With n-Butyl nitrite; potassium tert-butylate In tert-butyl alcohol for 0.5h; Ambient temperature;66%
Multi-step reaction with 2 steps
1: 22 percent / potassium t-butoxide, propyl nitrate / tetrahydrofuran / 2.5 h / Ambient temperature
2: 50.4 percent / ethanol / 3 h / Irradiation
View Scheme
Multi-step reaction with 3 steps
1: 22 percent / potassium t-butoxide, propyl nitrate / tetrahydrofuran / 2.5 h / Ambient temperature
2: 25.2 percent / ethanol / 3 h / Irradiation
3: 140 °C
View Scheme
coprostanone
601-53-6

coprostanone

4β-iodo-5β-cholestan-3-one
78806-58-3

4β-iodo-5β-cholestan-3-one

Conditions
ConditionsYield
With copper diacetate; iodine In acetic acid at 60℃; for 6h;65%
With ammonium cerium(IV) nitrate; iodine In water; acetic acid at 50℃; for 2.5h;60%
coprostanone
601-53-6

coprostanone

thiophenol
108-98-5

thiophenol

(5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-3-phenylsulfanyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene
88904-77-2

(5R,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-3-phenylsulfanyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

Conditions
ConditionsYield
Montmorillonite KSF In toluene for 6h; Heating;62%
coprostanone
601-53-6

coprostanone

(5S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-4-iodo-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one

(5S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-4-iodo-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; iodine In water; acetic acid at 50℃; for 2.5h; Iodination;60%

601-53-6Relevant articles and documents

Reduction of a Δ4-steroid with diborane

D'Alessandro,Giacopello,Seldes,Deluca

, p. 2703 - 2708 (1995)

Reported here is a boron process equivalent to stereoselective olefin reduction and concomitant protecting group cleavage.

Iron-Catalyzed Chemoselective Reduction of α,β-Unsaturated Ketones

Lator, Alexis,Gaillard, Sylvain,Poater, Albert,Renaud, Jean-Luc

supporting information, p. 5770 - 5774 (2018/03/26)

An iron-catalyzed chemo- and diastereoselective reduction of α,β-unsaturated ketones into the corresponding saturated ketones in mild reaction conditions is reported herein. DFT calculations and experimental work underline that transfer hydride reduction is a more facile process than hydrogenation, unveiling the fundamental role of the base.

Direct organocatalytic stereoselective transfer hydrogenation of conjugated olefins of steroids

Ramachary, Dhevalapally B.,Sakthidevi, Rajasekar,Reddy, P. Srinivasa

, p. 13497 - 13506 (2013/09/02)

Kinetically controlled and organocatalytic syn-selective transfer hydrogenation has been successfully demonstrated for the reduction of the enone functional group of various steroids. Herein, diastereoselective synthesis of many 5β-steroids have been reported through organocatalysis, which have broad medicinal and pharmaceutical applications. The mechanistic studies and the selectivity of the products clearly indicated that the catalyst 1b·d-CSA is mild enough to activate the various chiral cyclic enones through iminium ion formation during the organocatalytic transfer hydrogenations with Hantzsch ester 2a as a hydrogen source. Further, clear evidence for the selective formation of intermediate iminium species [I]+ have been characterized through on-line monitoring of controlled experiments by NMR and ESI-HRMS analyses.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 601-53-6